tranexamic acid has been researched along with Liver Cirrhosis in 10 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
"To report a case of toxic epidermal necrolysis (TEN) induced by orally administered tranexamic acid in a patient with liver cirrhosis and acute rectal bleeding." | 3.79 | Tranexamic acid-induced toxic epidermal necrolysis. ( Aguado Gil, L; Idoate Gastearena, MA; Marques Martin, L; Pretel Irazabal, M, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Louro, J | 1 |
Andersen, K | 1 |
Dudaryk, R | 1 |
Heidet, M | 1 |
Amathieu, R | 1 |
Audureau, E | 1 |
Augusto, O | 1 |
Nicolazo de Barmon, V | 1 |
Rialland, A | 1 |
Schmitz, D | 1 |
Pierrang, F | 1 |
Marty, J | 1 |
Chollet-Xémard, C | 1 |
Thirion, O | 1 |
Jacob, L | 1 |
Dibiasi, C | 1 |
Wiegele, M | 1 |
Gratz, J | 1 |
Pretel Irazabal, M | 1 |
Marques Martin, L | 1 |
Aguado Gil, L | 1 |
Idoate Gastearena, MA | 1 |
Joshi, N | 1 |
Kopec, AK | 1 |
Towery, K | 1 |
Williams, KJ | 1 |
Luyendyk, JP | 1 |
Perdigão, JP | 1 |
de Almeida, PC | 1 |
Rocha, TD | 1 |
Mota, MR | 1 |
Soares, EC | 1 |
Alves, AP | 1 |
Sousa, FB | 1 |
Ickx, BE | 1 |
van der Linden, PJ | 1 |
Melot, C | 1 |
Wijns, W | 1 |
de Pauw, L | 1 |
Vandestadt, J | 1 |
Hut, F | 1 |
Pradier, O | 1 |
McCormick, PA | 1 |
Ooi, H | 1 |
Crosbie, O | 1 |
Burak, KW | 1 |
Lee, SS | 1 |
Beck, PL | 1 |
Maeda, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy and Safety of Early Administration of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding: a Multicenter, Randomized, Double Blind, Placebo-controlled Trial (Modified by amendment1)[NCT03023189] | Phase 4 | 500 participants (Anticipated) | Interventional | 2017-04-03 | Recruiting | ||
Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population[NCT05317806] | Phase 4 | 15 participants (Anticipated) | Interventional | 2022-10-10 | Active, not recruiting | ||
Efficacy of Local Hemostatic Management in Implant Surgery in Anticoagulated Patients on Warfarin: a Randomized Clinical Study[NCT04846114] | 71 participants (Actual) | Interventional | 2016-03-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for tranexamic acid and Liver Cirrhosis
Article | Year |
---|---|
Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.
Topics: Adrenergic beta-Antagonists; Antifibrinolytic Agents; Diagnosis, Differential; Esophageal and Gastri | 2001 |
3 trials available for tranexamic acid and Liver Cirrhosis
Article | Year |
---|---|
Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study)
Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Double-Blind Method; France; Gastrointe | 2018 |
Postoperative bleeding after dental extraction in liver pretransplant patients.
Topics: Adult; Antifibrinolytic Agents; Cross-Sectional Studies; Dental Care for Chronically Ill; Female; He | 2012 |
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Topics: Adult; Aprotinin; Blood Loss, Surgical; Erythrocyte Transfusion; Female; Fibrinolysis; Hemostatics; | 2006 |
6 other studies available for tranexamic acid and Liver Cirrhosis
Article | Year |
---|---|
Correction of Severe Coagulopathy and Hyperfibrinolysis by Tranexamic Acid and Recombinant Factor VIIa in a Cirrhotic Patient After Trauma: A Case Report.
Topics: Aged; Antifibrinolytic Agents; Blood Coagulation; Factor VIIa; Humans; Liver Cirrhosis; Male; Recomb | 2017 |
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis.
Topics: Aged; Blood Loss, Surgical; Carcinoma, Hepatocellular; Dabigatran; Humans; Infusions, Intravenous; L | 2019 |
Tranexamic acid-induced toxic epidermal necrolysis.
Topics: Aged; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Stevens-J | 2013 |
The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
Topics: 1-Naphthylisothiocyanate; Animals; Antifibrinolytic Agents; Bile Duct Diseases; Collagen Type I; Dis | 2014 |
Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis.
Topics: Aged; Antifibrinolytic Agents; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Stomach | 1998 |
[A study on pathogenesis of gastric ulcer in patient with liver cirrhosis: with special reference to the gastric mucosal blood flow].
Topics: Adult; Anti-Ulcer Agents; Gastric Mucosa; Humans; Liver Cirrhosis; Middle Aged; Regional Blood Flow; | 1988 |